zoledronic acid has been researched along with folic acid in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 6 (85.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Gogia, N; Kumar, R; Mahapatra, M; Malik, M; Pillai, LS; Puri, T; Sharma, DN | 1 |
Anastasilakis, AD; Arsos, G; Barmpalios, G; Efstathiadou, Z; Kita, M; Litsas, I; Makrigiannaki, E; Moralidis, E; Panagiotou, A; Papatheodorou, A; Polyzos, SA; Terpos, E; Triantafillidou, E; Zafeiriadou, E | 1 |
Amitay, Y; Gabizon, A; Gorin, J; Kumar, S; Mak, L; Ogorka, J; Shmeeda, H; Tzemach, D; Zhang, JA | 1 |
Amitay, Y; Gabizon, A; Gorin, J; Shmeeda, H; Tzemach, D | 1 |
Hattori, Y; Kawano, K; Sakaida, C; Yamashita, J; Yonemochi, E | 1 |
Au, KM; Caster, JM; Huang, L; Kim, YS; Min, Y; Satterlee, A; Tian, X; Wang, AZ; Zhang, L; Zhang, T | 1 |
1 review(s) available for zoledronic acid and folic acid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for zoledronic acid and folic acid
Article | Year |
---|---|
Serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone: the effect of zoledronic acid.
Topics: 25-Hydroxyvitamin D 2; Aged; Alkaline Phosphatase; Biomarkers; Body Mass Index; Bone Density Conservation Agents; Bone Neoplasms; Bone Remodeling; Calcifediol; Cohort Studies; Collagen Type I; Diphosphonates; Female; Folic Acid; Homocysteine; Humans; Imidazoles; Isoenzymes; Male; Paget Disease, Extramammary; Peptides; Pilot Projects; Time Factors; Vitamin B 12; Zoledronic Acid | 2010 |
5 other study(ies) available for zoledronic acid and folic acid
Article | Year |
---|---|
Paraplegia due to extramedullary hematopoiesis in thalassemia treated successfully with radiation therapy.
Topics: Adult; beta-Thalassemia; Blood Transfusion; Calcium; Cobalt Radioisotopes; Contraindications; Decompression, Surgical; Diphosphonates; Epidural Space; Folic Acid; Fractures, Spontaneous; Hematopoiesis, Extramedullary; Humans; Imidazoles; Male; Osteoporosis; Paraplegia; Radioisotope Teletherapy; Spinal Cord Compression; Zoledronic Acid | 2007 |
Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Diphosphonates; Drug Carriers; Drug Compounding; Drug Stability; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Imidazoles; Lipid Bilayers; Liposomes; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Phospholipids; Protein Binding; Zoledronic Acid | 2010 |
Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity.
Topics: Animals; Bone Density Conservation Agents; Diphosphonates; Female; Folic Acid; Imidazoles; Lipids; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Polyethylene Glycols; Tissue Distribution; Zoledronic Acid | 2013 |
Evaluation of antitumor effect of zoledronic acid entrapped in folate-linked liposome for targeting to tumor-associated macrophages.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Diphosphonates; Female; Folic Acid; Humans; Imidazoles; KB Cells; Liposomes; Macrophages; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Neovascularization, Pathologic; Tumor Cells, Cultured; Zoledronic Acid | 2015 |
Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeutic.
Topics: Antineoplastic Agents; Apoptosis; Bone Density Conservation Agents; Calcium; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Diphosphonates; Folic Acid; Humans; Hydrogen-Ion Concentration; Imidazoles; Metals; Nanocapsules; Nanocomposites; Neoplasms, Experimental; Organic Chemicals; Treatment Outcome; Zoledronic Acid | 2016 |